Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
Status:
Not yet recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group,
multi-site, clinical trial to confirm the efficacy and safety of repeated topical application
of Qutenza (capsaicin 8% topical system) versus low-dose capsaicin control (capsaicin 0.04%
topical system) in subjects with moderate to severe postsurgical neuropathic pain (PSNP).